Bioscience campus, managed by Manchester Science Partnerships (MSP), which provides over 1m sq ft of office and lab space to businesses in the life sciences sector and support for companies from startup to scaleup.
Acquired by Bruntwood in 2014 and currently undergoing a £160m investment, Alderley Park is home to the internationally-recognised Mereside bioscience campus managed by Manchester Science Partnerships (MSP).
As well as providing over 1m sq ft of state-of-art office and lab space to businesses in the life sciences sector, the site provides support for companies, from startup to scaleup, supporting the development of products for universities, hospitals and institutes as well as corporates.
All companies on site have access to Alderley Park’s flexible infrastructure and scientific services, which allows them to start small (such as a hot desk or single lab bench) and then to expand as their business develops and grows. There are now 65 physical companies on site, the number having grown from 16 in 2013 and over 1,200 employees compared to 47 in the first year.
Following participation in the DEG course in 2018, the Alderley Park biotech business support service – the Accelerator, powered by BioCity – developed a specific Scale-Up Programme to support rapid growth. Through bespoke one-to-one engagement and expertise both onsite and offsite, companies are supported with leadership skills and development, access to finance options and international markets.
Other services available relate to raising company profiles and acquiring the right talent and skills through the site’s engagement with universities. Structured support is also available for biotech startups at Alderley Park with a focused Pre-Accelerator and Accelerator programme.
Early in its development, Alderley Park recognised the importance of mentoring and the significant impact a small number of entrepreneurs, business angels and venture capitalists could have on the growth of the site and the companies based there.
In 2014 an Expert Mentor Network was established building on the links with senior industry leaders who wanted to contribute to the site’s future success. Currently there are over 200 mentors within the network, all of whom are fully integrated into the programmes, providing unique access to global pharma leaders and their networks, as well as senior finance and business executives. Regular network events are also held during which companies can ask the mentors for support in specific areas of business. For scaleups access to markets and funding support have been particular asks.
If you know any national or local scaleup programmes that you want to recommend as a potential case study for the Institute to consider please do get in touch: email@example.com